Trial Profile
Diagnosing Pancreatic-Based Malabsorption in Patients With Chronic Pancreatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Pancrelipase (Primary)
- Indications Exocrine pancreatic insufficiency; Pancreatitis
- Focus Diagnostic use; Therapeutic Use
- 10 Apr 2019 Status changed from recruiting to completed.
- 02 Feb 2018 Planned End Date changed from 1 Mar 2018 to 1 Dec 2018.
- 02 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.